Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Precision BioSciences stock | $10.53
Learn how to easily invest in Precision BioSciences stock.
Precision BioSciences, Inc is a biotechnology business based in the US. Precision BioSciences shares (DTIL) are listed on the NASDAQ and all prices are listed in US Dollars. Precision BioSciences employs 237 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Precision BioSciences
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – DTIL – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Precision BioSciences stock price (NASDAQ: DTIL)Use our graph to track the performance of DTIL stocks over time.
Precision BioSciences shares at a glance
|Latest market close||$10.53|
|52-week range||$4.55 - $16.60|
|50-day moving average||$11.27|
|200-day moving average||$10.87|
|Wall St. target price||$18.88|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-3.12|
Buy Precision BioSciences shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Precision BioSciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Precision BioSciences price performance over time
|1 week (2021-07-18)||N/A|
|1 month (2021-06-29)||-12.61%|
|3 months (2021-04-29)||10.03%|
|6 months (2021-01-25)||N/A|
|1 year (2020-07-25)||N/A|
|2 years (2019-07-25)||N/A|
|3 years (2018-07-25)||N/A|
|5 years (2016-07-25)||N/A|
Precision BioSciences financials
|Revenue TTM||$33.6 million|
|Gross profit TTM||$24.3 million|
|Return on assets TTM||-26.51%|
|Return on equity TTM||-116.03%|
|Market capitalisation||$604.7 million|
TTM: trailing 12 months
Shorting Precision BioSciences shares
There are currently 3.2 million Precision BioSciences shares held short by investors – that's known as Precision BioSciences's "short interest". This figure is 42.4% down from 5.5 million last month.
There are a few different ways that this level of interest in shorting Precision BioSciences shares can be evaluated.
Precision BioSciences's "short interest ratio" (SIR)
Precision BioSciences's "short interest ratio" (SIR) is the quantity of Precision BioSciences shares currently shorted divided by the average quantity of Precision BioSciences shares traded daily (recently around 843643.5828877). Precision BioSciences's SIR currently stands at 3.74. In other words for every 100,000 Precision BioSciences shares traded daily on the market, roughly 3740 shares are currently held short.
However Precision BioSciences's short interest can also be evaluated against the total number of Precision BioSciences shares, or, against the total number of tradable Precision BioSciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Precision BioSciences's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Precision BioSciences shares in existence, roughly 50 shares are currently held short) or 0.0666% of the tradable shares (for every 100,000 tradable Precision BioSciences shares, roughly 67 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Precision BioSciences.
Find out more about how you can short Precision BioSciences stock.
Precision BioSciences share dividends
We're not expecting Precision BioSciences to pay a dividend over the next 12 months.
Precision BioSciences share price volatility
Over the last 12 months, Precision BioSciences's shares have ranged in value from as little as $4.55 up to $16.6. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Precision BioSciences's is 1.6893. This would suggest that Precision BioSciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Precision BioSciences overview
Precision BioSciences, Inc. , a genome editing company, develops therapeutic products in the United States. The company operates through two segments, Therapeutic and Food. It offers ARCUS, a genome editing platform to cure genetic disorders. The Therapeutic segment develops allogeneic CAR T immunotherapy that recognizes and kills cancer cells; and engages in the in vivo gene correction activities. This segment develops PBCAR0191, which is in Phase 1/2a clinical trial, an allogeneic anti-CD19 CAR T cell product candidate for the patients with relapsed or refractory, or R/R, non-Hodgkin lymphoma, or NHL, or R/R B-cell precursor acute lymphoblastic leukemia, or B-ALL; and PBCAR20A, that is in Phase 1/2a clinical trial, an allogeneic anti-CD20 CAR T therapy for the treatment NHL, chronic lymphocytic leukemia, and small lymphocytic lymphoma, as well as developing PBCAR269A, which is in Phase 1/2a clinical trial, an allogeneic anti-BCMA CAR T cell product candidate for the treatment of R/R multiple myeloma. The Food segment develops food and nutrition products; and provides technology-centric solutions, Elo life systems, and Elo's technology platform solutions.
Stocks similar to Precision BioSciences
Precision BioSciences in the news
Update: Precision BioSciences (NASDAQ:DTIL) Stock Gained 32% In The Last Year
DTIL Crosses Below Key Moving Average Level
Piper Sandler biotech analysts hold an analyst/industry conference call
Frequently asked questionsWhat percentage of Precision BioSciences is owned by insiders or institutions?
Currently 11.479% of Precision BioSciences shares are held by insiders and 61.881% by institutions. How many people work for Precision BioSciences?
Latest data suggests 237 work at Precision BioSciences. When does the fiscal year end for Precision BioSciences?
Precision BioSciences's fiscal year ends in December. Where is Precision BioSciences based?
Precision BioSciences's address is: 302 East Pettigrew Street, Durham, NC, United States, 27701 What is Precision BioSciences's ISIN number?
Precision BioSciences's international securities identification number is: US74019P1084 What is Precision BioSciences's CUSIP number?
Precision BioSciences's Committee on Uniform Securities Identification Procedures number is: 74019P108
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert